---
title: "Morgan Stanley expects that the stock price of China Traditional Chinese Medicine will decline in the next 30 days"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273933723.md"
description: "Morgan Stanley expects the stock price of TRAD CHI MED to decline within the next 30 days, with a probability of 70% to 80%. The firm has adjusted its rating to \"Underweight\" and set a target price of 1.5 yuan. The reason is that the company is expected to record a loss in the fiscal year 2025 and has not disclosed specific market expansion plans, leading to low visibility on the 2026 performance, with expectations that the stock price still has downside potential"
datetime: "2026-01-28T04:25:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273933723.md)
  - [en](https://longbridge.com/en/news/273933723.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273933723.md)
---

# Morgan Stanley expects that the stock price of China Traditional Chinese Medicine will decline in the next 30 days

Morgan Stanley published a technical research report indicating that it believes the stock price of China Traditional Chinese Medicine (00570.HK) will decline in the next 30 days, with the probability of this occurring estimated to be between 70% and 80%. The rating is "Underweight," with a target price of HKD 1.50.

Morgan Stanley stated that the expected stock price fluctuation is due to a profit warning, as the company anticipates recording a loss for the fiscal year 2025, which would be the first since 2013. The firm believes that, facing the challenge of a shrinking market size, the company has not disclosed specific plans for expanding into new markets through internal resources or acquisitions. Therefore, the market currently has low visibility regarding the company's performance in 2026, and it is expected that the stock price still has further downside potential

### Related Stocks

- [00570.HK](https://longbridge.com/en/quote/00570.HK.md)

## Related News & Research

- [China Traditional Chinese Medicine Holdings Co. Limited Held Extraordinary General Meeting](https://longbridge.com/en/news/274502178.md)
- [China TCM Wins Shareholder Approval for 2026–2028 Financial, Purchase and Supply Frameworks](https://longbridge.com/en/news/274505643.md)
- [Exchange Seeks Clarification From eMudhra After Sharp Share Price Move](https://longbridge.com/en/news/282221836.md)
- [Hindcon Chemicals Responds to Exchange After Sharp Share Price Move](https://longbridge.com/en/news/282310762.md)
- [Here's What to Expect From Seagate Technology's Next Earnings Report](https://longbridge.com/en/news/282556849.md)